Detalhe da pesquisa
1.
Clinical applications of deep learning in neuroinflammatory diseases: A scoping review.
Rev Neurol (Paris)
; 2024 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38772806
2.
A decade of fingolimod in multiple sclerosis: Insights from a large real-world cohort study.
Rev Neurol (Paris)
; 179(6): 576-584, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36841644
3.
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.
BMC Med Res Methodol
; 22(1): 155, 2022 05 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35637426
4.
Atypical myelitis in patients with multiple sclerosis: Characterization and comparison with typical multiple sclerosis and neuromyelitis optica spectrum disorders.
Mult Scler
; 27(2): 232-238, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32077365
5.
Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection.
Rev Neurol (Paris)
; 177(10): 1237-1240, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34172292
6.
Identification and measurement of cervical spinal cord atrophy in neuromyelitis optica spectrum disorders (NMOSD) and correlation with clinical characteristics and cervical spinal cord MRI data.
Rev Neurol (Paris)
; 177(1-2): 85-92, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-32753321
7.
A comparative evaluation of different neuromyelitis optica spectrum disorder sets of criteria.
Eur J Neurol
; 27(11): 2250-2256, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32559008
8.
MSCopilot, a new multiple sclerosis self-assessment digital solution: results of a comparative study versus standard tests.
Eur J Neurol
; 27(3): 429-436, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31538396
9.
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Yes.
Rev Neurol (Paris)
; 176(6): 497-499, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32265072
10.
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.
J Neuroinflammation
; 15(1): 134, 2018 May 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29724224
11.
Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder.
Rev Neurol (Paris)
; 174(10): 675-679, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-30293882
12.
Is the Choosing Wisely® campaign model applicable to the management of multiple sclerosis in France? A GRESEP pilot study.
Rev Neurol (Paris)
; 174(1-2): 28-35, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29128151
13.
[MOG encephalomyelitis: international recommendations on diagnosis and antibody testing]. / MOG-Enzephalomyelitis: Internationale Empfehlungen zu Diagnose und Antikörpertestung.
Nervenarzt
; 89(12): 1388-1399, 2018 Dec.
Artigo
Alemão
| MEDLINE | ID: mdl-30264269
14.
Reverse Takotsubo cardiomyopathy as a complication of MOG-antibody-associated disease (MOGAD)? A case report.
Rev Neurol (Paris)
; 178(9): 981-983, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36424677
15.
Efficacy of rituximab in refractory neuromyelitis optica.
Mult Scler
; 22(7): 955-9, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26362900
16.
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Rev Neurol (Paris)
; 172(4-5): 256-62, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27157418
17.
Chronic inflammatory demyelinating polyradiculoneuropathy: A new animal model for new therapeutic targets.
Rev Neurol (Paris)
; 172(12): 767-769, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27838091
18.
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.
Mult Scler
; 21(6): 678-88, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25662342
19.
Covid-19, the pandemic war: Implication for neurologists.
Rev Neurol (Paris)
; 176(4): 223-224, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32303331
20.
Tear analysis as a tool to detect oligoclonal bands in radiologically isolated syndrome.
Rev Neurol (Paris)
; 171(4): 390-3, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25613196